Search

Your search keyword '"Naleway, Allison L."' showing total 59 results

Search Constraints

Start Over You searched for: Author "Naleway, Allison L." Remove constraint Author: "Naleway, Allison L." Publisher elsevier bv Remove constraint Publisher: elsevier bv
59 results on '"Naleway, Allison L."'

Search Results

2. Postmenopausal bleeding after COVID-19 vaccination

3. Racial and ethnic disparities in influenza vaccination coverage among pregnant women in the United States: The contribution of vaccine-related attitudes

4. Serum per- and polyfluoroalkyl substance concentrations and longitudinal change in post-infection and post-vaccination SARS-CoV-2 antibodies

5. Influenza vaccination coverage among persons ages six months and older in the Vaccine Safety Datalink in the 2017–18 through 2022–23 influenza seasons

6. Impact of accounting for correlation between COVID-19 and influenza vaccination in a COVID-19 vaccine effectiveness evaluation using a test-negative design

7. Simultaneous administration of mRNA COVID-19 bivalent booster and influenza vaccines

8. Number needed to vaccinate with a COVID-19 booster to prevent a COVID-19-associated hospitalization during SARS-CoV-2 Omicron BA.1 variant predominance, December 2021–February 2022, VISION Network: a retrospective cohort study

9. Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19–Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions — VISION Network, September 2022–April 2023

10. Effectiveness of COVID-19 Vaccines at Preventing Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompromised Adults: An Observational Study of Real-World Data Across 10 US States from August-December 2021

11. Tdap vaccination during pregnancy and risk of chorioamnionitis and related infant outcomes

14. COVID-19 vaccine perceptions and uptake in a national prospective cohort of essential workers

15. Risk of Myocarditis and Pericarditis Following BNT162b2 and mRNA-1273 COVID-19 Vaccination

16. Effectiveness of two-dose vaccination with mRNA COVID-19 vaccines against COVID-19–associated hospitalizations among immunocompromised adults—Nine States, January–September 2021

17. Monitoring vaccine safety using the vaccine safety Datalink: Assessing capacity to integrate data from Immunization Information systems

18. A multi-country investigation of influenza vaccine coverage in pregnant individuals, 2010–2016

19. Incidence of pediatric inflammatory bowel disease within the Vaccine Safety Datalink network and evaluation of association with rotavirus vaccination

20. Incidence of herpes zoster among varicella-vaccinated children, by number of vaccine doses and simultaneous administration of measles, mumps, and rubella vaccine

21. An international cohort study of birth outcomes associated with hospitalized acute respiratory infection during pregnancy

22. Trivalent inactivated influenza vaccine (IIV3) during pregnancy and six-month infant development

24. Uptake and safety of hepatitis A vaccination during pregnancy: A Vaccine Safety Datalink study

25. Inactivated influenza vaccine and spontaneous abortion in the Vaccine Safety Datalink in 2012–13, 2013–14, and 2014–15

27. Similar relative risks of seizures following measles containing vaccination in children born preterm compared to full-term without previous seizures or seizure-related disorders

28. Uptake and safety of Hepatitis B vaccination during pregnancy: A Vaccine Safety Datalink study

33. Association of spontaneous abortion with receipt of inactivated influenza vaccine containing H1N1pdm09 in 2010–11 and 2011–12

34. First Trimester Influenza Vaccination and Risks for Major Structural Birth Defects in Offspring

35. Maternal Tdap vaccination and risk of infant morbidity

37. 530: Maternal and infant outcomes following inadvertent hpv vaccination

39. Influenza Vaccination During Pregnancy

40. Maternal Tdap vaccination: Coverage and acute safety outcomes in the vaccine safety datalink, 2007–2013

41. Absence of venous thromboembolism risk following quadrivalent human papillomavirus vaccination, Vaccine Safety Datalink, 2008–2011

43. Demographic characteristics of members of the Vaccine Safety Datalink (VSD): A comparison with the United States population

46. Childhood vaccines and Kawasaki disease, Vaccine Safety Datalink, 1996-2006

49. The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety

Catalog

Books, media, physical & digital resources